Abstract
Viral diseases in children can present with characteristic mucocutaneous manifestations. This article focuses, from a practical clinical point of view, on the laboratory and clinical diagnoses, and treatment of pediatric dermatological diseases that have specific antiviral therapies: herpes virus infections (including varicella), papillomavirus infections and molluscum contagiosum.
Special issues, such as viral infections in pregnancy, therapy of viral infections in immunosuppressed children, as well as special problems associated with the epidemiology of genital herpes and papillomavirus infections in adolescents are discussed.
The antivirals discussed in detail include: aciclovir, valaciclovir, famciclovir, penciclovir, cidofovir, foscar-net and the immune response modulator, imiquimod. Since these antiviral drugs generally have not been evaluated in children, caution should be exercised with their usage.
Similar content being viewed by others
References
Recommended childhood immunization schedule, United States, January-December. Committee on Infectious Diseases. Pediatrics 2001; 107: 202–4
Raimer SS, Raimer BG. Family violence, child abuse, and anogenital warts. Arch Dermatol 1992; 128: 842–4
Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12: 1–8
Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs 1999; 57: 187–206
Simonart T, Noel JC, De Dobbeleer G, et al. Treatment of classical Kaposi’s sarcoma with intralesional injections of cidofovir: report of a case. J Med Virol 1998; 55: 215–8
Meadows KP, Tyring SK, Pavia AT, et al. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol 1997; 133: 987–90
Tyring S. Immune response modification: imiquimod. Australas J Dermatol 1998; 39Suppl. 1: S11–3
Trizna Z, Tyring SK. Antiviral treatment of diseases in pediatric dermatology. Dermatol Clin 1998; 16: 539–52
Kesson AM. Use of acyclovir in herpes simplex virus infections. J Paediar Child Health 1998; 34: 9–13
Amir J, Harel L, Smetana Z, et al. Treatment of herpes simplex gingivostomatitis with acyclovir in children: a randomised double blind placebo controlled study. BMJ 1997; 314: 1800–3
Schwartz GS, Holland EJ. Oral acyclovir for the management of herpes simplex virus keratitis in children. Ophthalmology 2000; 107: 278–82
Gutierrez KM, Falkovitz Halpern MS, Maldonado Y, et al. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis 1999; 180: 199–202
Weston WL, Morelli JG. Herpes simplex virus-associated erythema multiforme in prepubertal children. Arch Pediatr Adolesc Med 1997; 151: 1014–6
Theriault A, Cohen PR. Herpetic geometric glossitis in a pediatric patient with acute myelogenous leukemia. Am J Clin Oncol 1997; 20: 567–8
McGill SN, Cartotto RC. Herpes simplex virus infection in a paediatric burn patient: case report and review. Burns 2000; 26: 194–9
Jang KA, Kim SH, Choi JH, et al. Viral folliculitis on the face. Br J Dermatol 2000; 142: 555–9
Gutman LT, Herman-Giddens ME, Phelps WC. Transmission of human genital papillomavirus disease: comparison of data from adults and children. Pediatrics 1993; 91: 31–8
Raguin G, Malkin JE. Genital herpes: epidemiology and pathophysiology. Update and new perspectives. Ann Med Intern Fenn 1997; 148: 530–3
Umene K, Kawana T. Molecular epidemiology of herpes simplex virus type 1 genital infection in association with clinical manifestations. Arch Virol 2000; 145: 505–22
Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am 1993; 7: 825–39
Stanberry L, Cunningham A, Mertz G, et al. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res 1999; 42: 1–14
Kimura H, Kido S, Ozaki T, et al. Comparison of quantitations of viral load in varicella and zoster. J Clin Microbiol 2000; 38: 2447–9
Tarlow MJ, Walters S. Chickenpox in childhood: a review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36Suppl. 1: S39–47
Ogilvie MM. Antiviral prophylaxis and treatment in chickenpox: a review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36Suppl. 1: 31–8
Chiodo F, Manfredi R, Antonelli P, et al. Varicella in immunocompetent children in the first two years of life: role of treatment with oral acyclovir. Italian Acyclovir-Chickenpox Study Group. J Chemother 1995; 7: 62–6
Kesson AM, Grimwood K, Burgess MA, et al. Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy. J Paediatr Child Health 1996; 32: 211–7
Suga S, Yoshikawa T, Yazaki T, et al. Dose-dependent effects of oral acyclovir in the incubation period of varicella. Acta Paediatr 1996; 85: 1418–21
Manfredi R, Chiodo F. Potential benefit of acyclovir for chickenpox acquired from household contacts. The Italian Acyclovir-Chickenpox Study Group. J Chemother 1997; 9: 199–202
Lin TY, Huang YC, Ning HC, et al. Oral acyclovir prophylaxis of varicella after intimate contact. Pediatr Infect Dis J 1997; 16: 1162–5
Kumagai T, Kamada M, Igarashi C, et al. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure. J Infect Dis 1999; 180: 834–7
Carcao MD, Lau RC, Gupta A, et al. Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children. Pediatr Infect Dis J 1998; 17: 626–31
Goldstein SL, Somers MJ, Lande MB, et al. Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediatr Nephrol 2000; 14(4): 305–8
Rothwell WS, Gloor JM, Morgenstern BZ, et al. Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil. Transplantation 1999; 68: 158–61
Leung TF, Chik KW, Li CK, et al. Incidence, risk factors and outcome of varicellazoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 25: 167–72
Chapman SJ. Varicella in pregnancy. Semin Perinatol 1998; 22(4): 339–46
Kakourou T, Theodoridou M, Mostrou G, et al. Herpes zoster in children. J Am Acad Dermatol 1998; 39 (2 Pt 1): 207–10
Petursson G, Helgason S, Gudmundsson S, et al. Herpes zoster in children and adolescents. Pediatr Infect Dis J 1998; 17: 905–8
Kimitsuki T, Komiyama S. Ramsay-Hunt syndrome in a 4-year-old child. Eur Arch Otorhinolaryngol 1999; 256Suppl. 1: S6–7
Laskaris G, Laskaris M, Theodoridou M. Oral hairy leukoplakia in a child with AIDS. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 570–1
Ginevri F, Losurdo G, Fontana I, et al. Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients. Transpl Int 1998; 11Suppl. 1: S130–4
Tyring SK. Human papillomavirus infections: epidemiology, pathogenesis, and host immune response. J Am Acad Dermatol 2000; 43 (1 Pt 2): S18–26
Kilkenny M, Marks R. The descriptive epidemiology of warts in the community. Australas J Dermatol 1996; 37: 80–6
Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984; 83: 18–25
Kenney JW, Reuss H. Human papillomavirus as expressed in cervical neoplasia: evolving diagnostic and treatment modalities. Health Care Women Int 1994; 15: 287–96
Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3–8
Franco EL. Epidemiology of anogenital warts and cancer. Obstetr Gynecol Clin North Am 1996; 23: 597–623
Gutman LT, St Claire KK, Everett VD, et al. Cervical-vaginal and intra-anal human papillomavirus infection of young girls with external genital warts. J Infect Dis 1994; 170: 339–44
Pransky SM, Magit AE, Kearns DB, et al. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 1999; 125: 1143–8
Zabawski Jr EJ, Sands B, Goetz D, et al. Treatment of verruca vulgaris with topical cidofovir [letter]. JAMA 1997; 278: 1236
Syed TA, Goswami J, Ahmadpour OA, et al. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol 1998; 25: 309–13
Zabawski Jr EJ, Cockerell CJ. Topical cidofovir for molluscum contagiosum in children. Pediatr Dermatol 1999; 16: 414–5
Toro JR, Wood LV, Patel NK, et al. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol 2000; 136: 983–5
Feuerstein B, Jurgens M, Schnetz E, et al. Cowpox and catpox infections: 2 clinicalcase reports. Hautarzt 2000; 51: 852–6
Acknowledgements
The authors would like to thank the Department of Dermatology, Texas Tech University, Lubbock, Texas, USA, for the use of slides in preparing the illustrations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trizna, Z. Viral Diseases of the Skin. Pediatr-Drugs 4, 9–19 (2002). https://doi.org/10.2165/00128072-200204010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128072-200204010-00002